Browsing by Subject "telehealth"
Now showing 1 - 2 of 2
Results Per Page
Sort Options
Item Awareness and intervention approaches related to smoking addiction among child and adolescent psychiatrists; [Çocuk ve ergen psikiyatristlerinin sigara bağımlılığı ile ilgili farkındalıkları ve müdahale yaklaşımları](2020) Erten T.; Sapmaz Ş.Y.; Güleç A.G.; Hesapçıoğlu S.T.; Kandemir H.; Yılmaz Ö.; Yüksel H.Aim: To determine the attitudes of child and adolescent psychiatrists working in different institutions throughout Turkey towards smoking addiction and intervention steps. Material and Methods: An information form assessing physicians’ 5As approach was established considering the studies included in the liter-ature, and this form was applied to physicians working in the area of child psychiatry by way of e-mail and phone. Results: Although most physicians (52.5%) asked about smoking status, which is included in the first step in the 5As approach used in smoking cessation, it was observed that they implemented further steps of the 5As with gradually decreasing rates in our study. Only 15% of the physicians performed follow-up in smoking cessation treatment. Conclusion: Physicians who work with pediatric and adolescent patients in Turkey have low levels of awareness about smoking addiction and they do not feel competent. Considering that tobacco and related addic-tions are gradually increasing in children and adolescents, physicians must receive training in the area of smoking cessation methods and start practicing these methods. It was thought that organizing smoking cessation training for physicians would contribute positively to the treatment of patients. © 2020 by Turkish Pediatric Association.Item Rhinitis associated with asthma is distinct from rhinitis alone: The ARIA-MeDALL hypothesis(John Wiley and Sons Inc, 2023) Bousquet J.; Melén E.; Haahtela T.; Koppelman G.H.; Togias A.; Valenta R.; Akdis C.A.; Czarlewski W.; Rothenberg M.; Valiulis A.; Wickman M.; Akdis M.; Aguilar D.; Bedbrook A.; Bindslev-Jensen C.; Bosnic-Anticevich S.; Boulet L.P.; Brightling C.E.; Brussino L.; Burte E.; Bustamante M.; Canonica G.W.; Cecchi L.; Celedon J.C.; Chaves Loureiro C.; Costa E.; Cruz A.A.; Erhola M.; Gemicioglu B.; Fokkens W.J.; Garcia-Aymerich J.; Guerra S.; Heinrich J.; Ivancevich J.C.; Keil T.; Klimek L.; Kuna P.; Kupczyk M.; Kvedariene V.; Larenas-Linnemann D.E.; Lemonnier N.; Lodrup Carlsen K.C.; Louis R.; Makela M.; Makris M.; Maurer M.; Momas I.; Morais-Almeida M.; Mullol J.; Naclerio R.N.; Nadeau K.; Nadif R.; Niedoszytko M.; Okamoto Y.; Ollert M.; Papadopoulos N.G.; Passalacqua G.; Patella V.; Pawankar R.; Pham-Thi N.; Pfaar O.; Regateiro F.S.; Ring J.; Rouadi P.W.; Samolinski B.; Sastre J.; Savouré M.; Scichilone N.; Shamji M.H.; Sheikh A.; Siroux V.; Sousa-Pinto B.; Standl M.; Sunyer J.; Taborda-Barata L.; Toppila-Salmi S.; Torres M.J.; Tsiligianni I.; Valovirta E.; Vandenplas O.; Ventura M.T.; Weiss S.; Yorgancioglu A.; Zhang L.; Abdul Latiff A.H.; Aberer W.; Agache I.; Al-Ahmad M.; Alobid I.; Ansotegui I.J.; Arshad S.H.; Asayag E.; Barbara C.; Baharudin A.; Battur L.; Bennoor K.S.; Berghea E.C.; Bergmann K.C.; Bernstein D.; Bewick M.; Blain H.; Bonini M.; Braido F.; Buhl R.; Bumbacea R.S.; Bush A.; Calderon M.; Calvo-Gil M.; Camargos P.; Caraballo L.; Cardona V.; Carr W.; Carreiro-Martins P.; Casale T.; Cepeda Sarabia A.M.; Chandrasekharan R.; Charpin D.; Chen Y.Z.; Cherrez-Ojeda I.; Chivato T.; Chkhartishvili E.; Christoff G.; Chu D.K.; Cingi C.; Correia de Sousa J.; Corrigan C.; Custovic A.; D’Amato G.; Del Giacco S.; De Blay F.; Devillier P.; Didier A.; do Ceu Teixeira M.; Dokic D.; Douagui H.; Doulaptsi M.; Durham S.; Dykewicz M.; Eiwegger T.; El-Sayed Z.A.; Emuzyte R.; Fiocchi A.; Fyhrquist N.; Gomez R.M.; Gotua M.; Guzman M.A.; Hagemann J.; Hamamah S.; Halken S.; Halpin D.M.G.; Hofmann M.; Hossny E.; Hrubiško M.; Irani C.; Ispayeva Z.; Jares E.; Jartti T.; Jassem E.; Julge K.; Just J.; Jutel M.; Kaidashev I.; Kalayci O.; Kalyoncu A.F.; Kardas P.; Kirenga B.; Kraxner H.; Kull I.; Kulus M.; La Grutta S.; Lau S.; Le Tuyet Thi L.; Levin M.; Lipworth B.; Lourenço O.; Mahboub B.; Martinez-Infante E.; Matricardi P.; Miculinic N.; Migueres N.; Mihaltan F.; Mohammad Y.; Moniuszko M.; Montefort S.; Neffen H.; Nekam K.; Nunes E.; Nyembue Tshipukane D.; O’Hehir R.; Ogulur I.; Ohta K.; Okubo K.; Ouedraogo S.; Olze H.; Pali-Schöll I.; Palomares O.; Palosuo K.; Panaitescu C.; Panzner P.; Park H.S.; Pitsios C.; Plavec D.; Popov T.A.; Puggioni F.; Quirce S.; Recto M.; Repka-Ramirez M.S.; Robalo Cordeiro C.; Roche N.; Rodriguez-Gonzalez M.; Romantowski J.; Rosario Filho N.; Rottem M.; Sagara H.; Serpa F.S.; Sayah Z.; Scheire S.; Schmid-Grendelmeier P.; Sisul J.C.; Sole D.; Soto-Martinez M.; Sova M.; Sperl A.; Spranger O.; Stelmach R.; Suppli Ulrik C.; Thomas M.; To T.; Todo-Bom A.; Tomazic P.V.; Urrutia-Pereira M.; Valentin-Rostan M.; Van Ganse E.; van Hage M.; Vasankari T.; Vichyanond P.; Viegi G.; Wallace D.; Wang D.Y.; Williams S.; Worm M.; Yiallouros P.; Yusuf O.; Zaitoun F.; Zernotti M.; Zidarn M.; Zuberbier J.; Fonseca J.A.; Zuberbier T.; Anto J.M.Asthma, rhinitis, and atopic dermatitis (AD) are interrelated clinical phenotypes that partly overlap in the human interactome. The concept of “one-airway-one-disease,” coined over 20 years ago, is a simplistic approach of the links between upper- and lower-airway allergic diseases. With new data, it is time to reassess the concept. This article reviews (i) the clinical observations that led to Allergic Rhinitis and its Impact on Asthma (ARIA), (ii) new insights into polysensitization and multimorbidity, (iii) advances in mHealth for novel phenotype definitions, (iv) confirmation in canonical epidemiologic studies, (v) genomic findings, (vi) treatment approaches, and (vii) novel concepts on the onset of rhinitis and multimorbidity. One recent concept, bringing together upper- and lower-airway allergic diseases with skin, gut, and neuropsychiatric multimorbidities, is the “Epithelial Barrier Hypothesis.” This review determined that the “one-airway-one-disease” concept does not always hold true and that several phenotypes of disease can be defined. These phenotypes include an extreme “allergic” (asthma) phenotype combining asthma, rhinitis, and conjunctivitis. Rhinitis alone and rhinitis and asthma multimorbidity represent two distinct diseases with the following differences: (i) genomic and transcriptomic background (Toll-Like Receptors and IL-17 for rhinitis alone as a local disease; IL-33 and IL-5 for allergic and non-allergic multimorbidity as a systemic disease), (ii) allergen sensitization patterns (mono- or pauci-sensitization versus polysensitization), (iii) severity of symptoms, and (iv) treatment response. In conclusion, rhinitis alone (local disease) and rhinitis with asthma multimorbidity (systemic disease) should be considered as two distinct diseases, possibly modulated by the microbiome, and may be a model for understanding the epidemics of chronic and autoimmune diseases. © 2023 The Authors. Allergy published by European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd.